Galeterone Study Sheds Light on Promising Next-Gen Therapies for Advanced Prostate Cancer

Galeterone Study Sheds Light on Promising Next-Gen Therapies for Advanced Prostate Cancer
A new study shows how galeterone is metabolized in the body, suggesting that it shares similarities with other steroidal anti-androgen drugs used to treat advanced prostate cancer. The finding could lay the foundation for development of next-generation drugs that offer better treatment options for the disease. The study titled, “Steroidogenic Metabolism of Galeterone Reveals a Diversity of Biochemical Activities,” was published in the journal Cell Chemical Biology. Prostate cancer growth is fueled by male androgens, such as testosterone. Generally, prostate cancer is sensitive to androgen deprivation therapy, also known as medica
Subscribe or to access all post and page content.